220 related articles for article (PubMed ID: 29499377)
1. Recent advances in brain tumor therapy: application of electrospun nanofibers.
Norouzi M
Drug Discov Today; 2018 Apr; 23(4):912-919. PubMed ID: 29499377
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
3. Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma.
Pena ES; Graham-Gurysh EG; Bachelder EM; Ainslie KM
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884965
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
5. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.
Agarwal S; Muniyandi P; Maekawa T; Kumar DS
Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
8. Glioma-astrocyte interactions on white matter tract-mimetic aligned electrospun nanofibers.
Grodecki J; Short AR; Winter JO; Rao SS; Winter JO; Otero JJ; Lannutti JJ; Sarkar A
Biotechnol Prog; 2015; 31(5):1406-15. PubMed ID: 26081199
[TBL] [Abstract][Full Text] [Related]
9. Targeted Vascular Drug Delivery in Cerebral Cancer.
Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
[TBL] [Abstract][Full Text] [Related]
10. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
Bagó JR; Pegna GJ; Okolie O; Mohiti-Asli M; Loboa EG; Hingtgen SD
Biomaterials; 2016 Jun; 90():116-25. PubMed ID: 27016620
[TBL] [Abstract][Full Text] [Related]
11. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
[TBL] [Abstract][Full Text] [Related]
12. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.
White E; Bienemann A; Taylor H; Hopkins K; Cameron A; Gill S
Contemp Clin Trials; 2012 Mar; 33(2):320-31. PubMed ID: 22101221
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in targeted drug delivery for the treatment of glioblastoma.
Mao M; Wu Y; He Q
Nanoscale; 2024 May; 16(18):8689-8707. PubMed ID: 38606460
[TBL] [Abstract][Full Text] [Related]
15. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
[TBL] [Abstract][Full Text] [Related]
16. Electrospun PVA-Dacarbazine nanofibers as a novel nano brain-implant for treatment of glioblastoma: in silico and in vitro characterization.
Steffens L; Morás AM; Arantes PR; Masterson K; Cao Z; Nugent M; Moura DJ
Eur J Pharm Sci; 2020 Feb; 143():105183. PubMed ID: 31846696
[TBL] [Abstract][Full Text] [Related]
17. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
[TBL] [Abstract][Full Text] [Related]
18. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
19. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
Sarkaria JN; Hu LS; Parney IF; Pafundi DH; Brinkmann DH; Laack NN; Giannini C; Burns TC; Kizilbash SH; Laramy JK; Swanson KR; Kaufmann TJ; Brown PD; Agar NYR; Galanis E; Buckner JC; Elmquist WF
Neuro Oncol; 2018 Jan; 20(2):184-191. PubMed ID: 29016900
[TBL] [Abstract][Full Text] [Related]
20. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
